The WNT signalling pathway and diabetes mellitus - PubMed (original) (raw)
Review
. 2008 Oct;51(10):1771-80.
doi: 10.1007/s00125-008-1084-y. Epub 2008 Aug 12.
Affiliations
- PMID: 18696049
- DOI: 10.1007/s00125-008-1084-y
Review
The WNT signalling pathway and diabetes mellitus
T Jin. Diabetologia. 2008 Oct.
Abstract
The WNT signalling pathway is involved in many physiological and pathophysiological activities. WNT ligands bind to Frizzled receptors and co-receptors (LDL receptor-related protein 5/6), triggering a cascade of signalling events. The major effector of the canonical WNT signalling pathway is the bipartite transcription factor beta-catenin/T cell transcription factor (beta-cat/TCF), formed by free beta-cat and one of the four TCFs. The WNT pathway is involved in lipid metabolism and glucose homeostasis, and mutations in LRP5 may lead to the development of diabetes and obesity. beta-Cat/TCF is also involved in the production of the incretin hormone glucagon-like peptide-1 in the intestinal endocrine L cells. More recently, genome-wide association studies have identified TCF7L2 as a diabetes susceptibility gene, and individuals carrying certain TCF7L2 single nucleotide polymorphisms could be more susceptible to the development of type 2 diabetes. Furthermore, beta-cat is able to interact with forkhead box transcription factor subgroup O (FOXO) proteins. Since FOXO and TCF proteins compete for a limited pool of beta-cat, enhanced FOXO activity during ageing and oxidative stress may attenuate WNT-mediated activities. These observations shed new light on the pathogenesis of type 2 diabetes as an age-dependent disease.
Comment in
- WNT signalling is both an inducer and effector of glucagon-like peptide-1.
Gustafson B, Smith U. Gustafson B, et al. Diabetologia. 2008 Oct;51(10):1768-70. doi: 10.1007/s00125-008-1109-6. Epub 2008 Jul 30. Diabetologia. 2008. PMID: 18665346 No abstract available.
Similar articles
- Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin.
Jin T, George Fantus I, Sun J. Jin T, et al. Cell Signal. 2008 Oct;20(10):1697-704. doi: 10.1016/j.cellsig.2008.04.014. Epub 2008 May 8. Cell Signal. 2008. PMID: 18555664 Review. - Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism.
Manolagas SC, Almeida M. Manolagas SC, et al. Mol Endocrinol. 2007 Nov;21(11):2605-14. doi: 10.1210/me.2007-0259. Epub 2007 Jul 10. Mol Endocrinol. 2007. PMID: 17622581 Review. - The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus.
Jin T, Liu L. Jin T, et al. Mol Endocrinol. 2008 Nov;22(11):2383-92. doi: 10.1210/me.2008-0135. Epub 2008 Jul 3. Mol Endocrinol. 2008. PMID: 18599616 Review. - Cross talk between the insulin and Wnt signaling pathways: evidence from intestinal endocrine L cells.
Yi F, Sun J, Lim GE, Fantus IG, Brubaker PL, Jin T. Yi F, et al. Endocrinology. 2008 May;149(5):2341-51. doi: 10.1210/en.2007-1142. Epub 2008 Feb 7. Endocrinology. 2008. PMID: 18258680 - Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity.
Hoogeboom D, Essers MA, Polderman PE, Voets E, Smits LM, Burgering BM. Hoogeboom D, et al. J Biol Chem. 2008 Apr 4;283(14):9224-30. doi: 10.1074/jbc.M706638200. Epub 2008 Feb 4. J Biol Chem. 2008. PMID: 18250171
Cited by
- Differential effects of type 1 diabetes mellitus and subsequent osteoblastic β-catenin activation on trabecular and cortical bone in a mouse model.
Chen S, Liu D, He S, Yang L, Bao Q, Qin H, Liu H, Zhao Y, Zong Z. Chen S, et al. Exp Mol Med. 2018 Dec 5;50(12):1-14. doi: 10.1038/s12276-018-0186-y. Exp Mol Med. 2018. PMID: 30518745 Free PMC article. - Decreased Serum Dickkopf-1 Levels After Hypoglycemic Therapy in Patients with Type 2 Diabetes Mellitus.
Gao F, Li C, Peng J, Lu W, Zhu W, Zhou J, Lu J, Ma X. Gao F, et al. Diabetes Metab Syndr Obes. 2022 Sep 5;15:2725-2732. doi: 10.2147/DMSO.S376988. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 36091484 Free PMC article. - Ameliorating and refining islet organoids to illuminate treatment and pathogenesis of diabetes mellitus.
Li Y, Xu M, Chen J, Huang J, Cao J, Chen H, Zhang J, Luo Y, Wang Y, Sun J. Li Y, et al. Stem Cell Res Ther. 2024 Jun 27;15(1):188. doi: 10.1186/s13287-024-03780-7. Stem Cell Res Ther. 2024. PMID: 38937834 Free PMC article. Review. - Role of resistant starch in improving gut health, adiposity, and insulin resistance.
Keenan MJ, Zhou J, Hegsted M, Pelkman C, Durham HA, Coulon DB, Martin RJ. Keenan MJ, et al. Adv Nutr. 2015 Mar 13;6(2):198-205. doi: 10.3945/an.114.007419. Print 2015 Mar. Adv Nutr. 2015. PMID: 25770258 Free PMC article. Review. - No association between LRP5 gene polymorphisms and bone and obesity phenotypes in Chinese male-offspring nuclear families.
Yu JB, Ke YH, He JW, Zhang H, Hu WW, Hu YQ, Li M, Liu YJ, Gu JM, Fu WZ, Gao G, Yue H, Xiao WJ, Zhang ZL. Yu JB, et al. Acta Pharmacol Sin. 2010 Nov;31(11):1464-9. doi: 10.1038/aps.2010.92. Epub 2010 Oct 18. Acta Pharmacol Sin. 2010. PMID: 20953208 Free PMC article.
References
- J Endocrinol. 2007 May;193(2):195-207 - PubMed
- Curr Biol. 1996 Dec 1;6(12):1664-8 - PubMed
- Mol Endocrinol. 1994 Dec;8(12):1646-55 - PubMed
- Cell Signal. 2008 Jan;20(1):219-29 - PubMed
- Development. 2006 May;133(10):2023-32 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous